BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15796960)

  • 1. Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model.
    Roshani L; Mallon P; Sjostrand E; Wedekind D; Szpirer J; Szpirer C; Hedrich HJ; Klinga-Levan K
    Cancer Genet Cytogenet; 2005 Apr; 158(2):137-41. PubMed ID: 15796960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization.
    Hamta A; Adamovic T; Heloua K; Levan G
    Cancer Genet Cytogenet; 2005 Jun; 159(2):123-8. PubMed ID: 15899383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the genetic background on the genome make-up of tumor cells.
    Falck E; Behboudi A; Klinga-Levan K
    Genes Chromosomes Cancer; 2012 May; 51(5):438-46. PubMed ID: 22250046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density marker loss of heterozygosity analysis of rat chromosome 10 in endometrial adenocarcinoma.
    Behboudi A; Levan G; Hedrich HJ; Klinga-Levan K
    Genes Chromosomes Cancer; 2001 Dec; 32(4):330-41. PubMed ID: 11746974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic imbalance on chromosome 10 in rat endometrial adenocarcinomas.
    Nordlander C; Behboudi A; Levan G; Levan KK
    Cancer Genet Cytogenet; 2005 Jan; 156(2):158-66. PubMed ID: 15642397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model.
    Roshani L; Wedekind D; Szpirer J; Taib Z; Szpirer C; Beckmann B; Rivière M; Hedrich HJ; Klinga-Levan K
    Int J Cancer; 2001 Dec; 94(6):795-9. PubMed ID: 11745480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization.
    Helou K; Walentinsson A; Beckmann B; Johansson A; Hedrich HJ; Szpirer C; Klinga-Levan K; Levan G
    Cancer Genet Cytogenet; 2001 Jun; 127(2):118-27. PubMed ID: 11425450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinoma as revealed by combined BAC/PAC FISH, chromosome painting, zoo-FISH, and allelotyping.
    Adamovic T; Trossö F; Roshani L; Andersson L; Petersen G; Rajaei S; Helou K; Levan G
    Genes Chromosomes Cancer; 2005 Oct; 44(2):139-53. PubMed ID: 15942940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
    Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
    Karlsson S; Holmberg E; Askerlund A; Levan KK
    Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization.
    Walentinsson A; Helou K; Wallenius V; Hedrich HJ; Szpirer C; Levan G
    Cancer Res; 2001 Nov; 61(22):8263-73. PubMed ID: 11719459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of human endometrial adenocarcinoma in an inbred rat model.
    Karlsson S; Klinga-Levan K
    Adv Exp Med Biol; 2008; 617():503-9. PubMed ID: 18497075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors.
    Samuelson E; Nordlander C; Levan G; Behboudi A
    Adv Exp Med Biol; 2008; 617():511-7. PubMed ID: 18497076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas.
    Nordlander C; Samuelson E; Klinga-Levan K; Behboudi A
    Adv Exp Med Biol; 2008; 617():519-25. PubMed ID: 18497077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC; Benavides F; LaCava M; Conti CJ
    Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer.
    Adamovic T; Hamta A; Roshani L; Lü X; Röhme D; Helou K; Klinga-Levan K; Levan G
    Cancer Genet Cytogenet; 2008 Jul; 184(1):9-21. PubMed ID: 18558284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization.
    Samuelson E; Levan K; Adamovic T; Levan G; Horvath G
    Cancer Genet Cytogenet; 2008 Feb; 181(1):25-30. PubMed ID: 18262049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability (MSI) analysis in patients with endometrial cancer.
    Dec G; Romanowicz-Makowska H; Smolarz B; Kulig A
    Pol J Pathol; 2005; 56(1):15-9. PubMed ID: 15921009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mapping of mammary tumor traits to rat chromosome 10 using a novel panel of consomic rats.
    Adamovic T; McAllister D; Rowe JJ; Wang T; Jacob HJ; Sugg SL
    Cancer Genet Cytogenet; 2008 Oct; 186(1):41-8. PubMed ID: 18786441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deriving evolutionary tree models of the oncogenesis of endometrial adenocarcinoma.
    Chen L; Nordlander C; Behboudi A; Olsson B; Levan KK
    Int J Cancer; 2007 Jan; 120(2):292-6. PubMed ID: 17066454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.